O
9.66
-0.27 (-2.72%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Oric Pharmaceuticals, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.6
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.63 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 7.93% |
| 机构持股比例 | 102.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| First Turn Management, Llc | 31 Mar 2025 | 2,027,430 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 19.00 (HC Wainwright & Co., 96.69%) | 购买 |
| 中 | 17.50 (81.16%) | |
| 低 | 15.00 (Ladenburg Thalmann, 55.28%) | 购买 |
| 平均值 | 17.25 (78.57%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 10.03 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 14 Aug 2025 | 19.00 (96.69%) | 购买 | 9.93 |
| JP Morgan | 14 Aug 2025 | 17.00 (75.98%) | 购买 | 9.93 |
| Guggenheim | 13 Aug 2025 | 18.00 (86.34%) | 购买 | 9.83 |
| Ladenburg Thalmann | 08 Jul 2025 | 15.00 (55.28%) | 购买 | 10.43 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合